Jan 8 (Reuters) - Celgene Corp on Monday forecast 2018 total revenue that was largely below analysts’ estimates, sending the company’s shares down 2.4 percent.
The company said it expects full-year revenue of $14.4 billion to $14.8 billion, compared with analysts average estimate of $14.83 billion, according to Thomson Reuters I/B/E/S. (Reporting by Akankshita Mukhopadhyay in Bengaluru; Editing by Savio D‘Souza)
 